Pericapsular Nerve Group Block for Elective Hip Arthroplasty

January 26, 2021 updated by: Centre Hospitalier Universitaire de Tivoli

Pericapsular Nerve Group Block for Analgesia After Hip Arthroplasty: a Randomized Double-Blind, Placebo-Controlled Trial.

This study examine the effect of Pericapsular Nerve Group (PENG) Block on analgesia after elective hip arthroplasty. Half of participants will receive a PENG Block with local anesthetic, while the other half will receive a PENG Block with a placebo.

Study Overview

Detailed Description

Optimized analgesia is crucial for early mobilization after hip arthroplasty. Regional anesthesia, like fascia iliaca block or femoral nerve block, have limited indication because of motor blockade whereas local infiltrations analgesia have shown conflicting analgesic efficacy results in hip arthroplasty.

Pericapsular nerve group (PENG) block is a new regional anesthesia technique targeting specifically sensory nerve branches of the hip articulation. It has been originally described in hip fracture patients.

The aim of this study is to evaluate the efficacy of PENG block on analgesia after elective hip arthroplasty.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • La Louviere, Belgium, 7100
        • Recruiting
        • CHU Tivoli
        • Contact:
          • Nicolas Van Rompaey, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 76 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Elective total hip arthroplasty
  • General anesthesia
  • Enhanced Recovery Program

Exclusion Criteria:

  • American Society of Anesthesiologists (ASA) Score > 2
  • Drug allergy
  • Significant psychiatric disturbances
  • Preoperative opioid use
  • Contraindication to acetaminophen, celecoxib, methylprednisolone or tranexamic acid
  • Body Mass Index > 40 kg/m²

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PENG group
PENG block with 20 ml of a mixture of 1% Lidocaine with 0,5% Ropivacaine and 1/400.000 Epinephrine
After induction of general anesthesia, PENG block with 20 ml of a mixture of 1% Lidocaine with 0,5% Ropivacaine and 1/400.000 Epinephrine will be performed as described by Giron-Arongo et al with a high frequency linear probe. A 22G 80 mm needle (SonoPlex, Pajunk ) will be used.
Placebo Comparator: Placebo group
PENG block with 20 ml of 0,9% saline
After induction of general anesthesia, PENG block with 20 ml of 0,9% saline will be performed as described by Giron-Arongo et al with a high frequency linear probe. A 22G 80 mm needle (SonoPlex, Pajunk ) will be used.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Score on first Mobilization
Time Frame: Postoperative time until midnight day 0
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain on first mobilization at day 0 after surgery
Postoperative time until midnight day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum Pain Score in Post-Anaesthesia Care Unit
Time Frame: Through postoperative time during Post Anesthesia Care Unit stay at day 0
Maximum Pain score evaluated in Post Anesthesia Care Unit by a a visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale])
Through postoperative time during Post Anesthesia Care Unit stay at day 0
Morphine Consumption at Day 0
Time Frame: Postoperative time until midnight day 0
Total of Piritramid, Oxycodone and Oxycodone Extended Released expressed as equivalent of morphine at day 0
Postoperative time until midnight day 0
Piritramid Consumption
Time Frame: Through the end of surgery until Post Anesthesia Care Unit discharge to the ward at day 0
Total of Piritramid use from the end of surgery until Post Anesthesia Care Unit discharge to the ward
Through the end of surgery until Post Anesthesia Care Unit discharge to the ward at day 0
Morphine Consumption at Day 1
Time Frame: Postoperative time during Post Anesthesia Care Unit stay at day 0
Total of Oxycodone and Oxycodone Extended Released expressed as equivalent of morphine at day 1
Postoperative time during Post Anesthesia Care Unit stay at day 0
Morphine Consumption at Day 2
Time Frame: Postoperative time until midnight day 2
Total of Oxycodone and Oxycodone Extended Released expressed as equivalent of morphine at day 2
Postoperative time until midnight day 2
Pain Score at Rest 2h Postop
Time Frame: 2 hours after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain at rest 2h after surgery
2 hours after surgery
Pain Score on mobilization 2h Postop
Time Frame: 2 hours after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain on mobilization 2h after surgery
2 hours after surgery
Pain Score at Rest 4h Postop
Time Frame: 4 hours after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain at rest 4h after surgery
4 hours after surgery
Pain Score on mobilization 4h Postop
Time Frame: 4 hours after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain on mobilization 4h after surgery
4 hours after surgery
Pain Score at Rest 6h Postop
Time Frame: 6 hours after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain at rest 6h after surgery
6 hours after surgery
Pain Score on mobilization 6h Postop
Time Frame: 6 hours after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain on mobilization 6h after surgery
6 hours after surgery
Pain Score at Rest Day 1 AM
Time Frame: Day 1 in the morning after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain at rest in the morning of day 1
Day 1 in the morning after surgery
Pain Score on mobilization Day 1 AM
Time Frame: Day 1 in the morning after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain on mobilization in the morning of day 1
Day 1 in the morning after surgery
Pain Score at Rest Day 1 PM
Time Frame: Day 1 in the afternoon after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain at rest in the afternoon of day 1
Day 1 in the afternoon after surgery
Pain Score on mobilization Day 1 PM
Time Frame: Day 1 in the afternoon after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain on mobilization in the afternoon of day 1
Day 1 in the afternoon after surgery
Pain Score at Rest Day 2 AM
Time Frame: Day 2 in the morning after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain at rest in the morning of day 2
Day 2 in the morning after surgery
Pain Score on mobilization Day 2 AM
Time Frame: Day 2 in the morning after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain on mobilization in the morning of day 2
Day 2 in the morning after surgery
Pain Score at Rest Day 2 PM
Time Frame: Day 2 in the afternoon after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain at rest in the afternoon of day 2
Day 2 in the afternoon after surgery
Pain Score on mobilization Day 2 PM
Time Frame: Day 2 in the afternoon after surgery
A visual analog pain scale anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) will be used to evaluate pain on mobilization in the afternoon of day 2
Day 2 in the afternoon after surgery
First Mobilization Success
Time Frame: Postoperative time until midnight day 0
Success rate of patients mobilized the day of surgery
Postoperative time until midnight day 0
Mean remifentanil Infusion Rate
Time Frame: Intraoperatively
Total infused remifentanil dose per kg body weight per minute of total operative time
Intraoperatively
Quadriceps weakness
Time Frame: Through postoperative time during Post Anesthesia Care Unit stay at day 0
Evaluation of quadriceps motricity by Neal test which consist in supporting the knee under the popliteal fossa and asking the patient to extend the knee against resistance.
Through postoperative time during Post Anesthesia Care Unit stay at day 0

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction after 24h
Time Frame: 24 hours after surgery
Patient satisfaction for the first 24h after surgery recorded with a scale from 0 (unsatisfied) to 10 (extremely satisfied).
24 hours after surgery
Length of hospital stay
Time Frame: During hospital stay, up to 1 week
Calculated as the number of days between the hospital admission and discharge dates.
During hospital stay, up to 1 week
PACU stay
Time Frame: Postoperative time during Post Anesthesia Care Unit stay at day 0
Time from the arrival in Post Anesthesia Care Unit until discharge to the ward
Postoperative time during Post Anesthesia Care Unit stay at day 0
Postoperative Nausea and Vomiting
Time Frame: PACU, at 2, 6, 24, and 48 hours
The incidence and severity of postoperative nausea (none=0, mild=1, moderate=2, severe=3), episodes of vomiting, and need for rescue antiemetics was also documented.
PACU, at 2, 6, 24, and 48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nicolas Van Rompaey, MD, CHU Tivoli

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2020

Primary Completion (Anticipated)

December 31, 2021

Study Completion (Anticipated)

March 15, 2022

Study Registration Dates

First Submitted

January 8, 2020

First Submitted That Met QC Criteria

January 13, 2020

First Posted (Actual)

January 18, 2020

Study Record Updates

Last Update Posted (Actual)

January 27, 2021

Last Update Submitted That Met QC Criteria

January 26, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on PENG Block with local anesthetic

Subscribe